Companies researching Xtandi (Enzalutamide)
Enzalutamide, marketed under the brand name Xtandi, is a nonsteroidal antiandrogen drug used to treat prostate cancer.
8
companies
List of companies that research Xtandi (Enzalutamide)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
 Japan | Pharmaceutical Manufacturing | 13k | Xtandi (Enzalutamide) | ||
 United Kingdom | Research Services | 1.6k | $35M | Xtandi (Enzalutamide) | |
 Brazil | Pharmaceutical Manufacturing | 14k | Xtandi (Enzalutamide) | ||
 United States | Pharmaceutical Manufacturing | 109k | $100B | Xtandi (Enzalutamide) |
Showing top companies out of 8 that research Xtandi (Enzalutamide). Get the full list on TheirStack.
Frequently asked questions